ERNAW
Ernexa Therapeutics Inc. Warrants
NASDAQ · Financial Services · Asset Management · US
$0.04
−8.13%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-166.0%
Return on equity
-108.0%
Return on assets
-139.8%
Return on invested capital
0.00x
Asset turnover
-$7.2M
Cash from operations
$1.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026